摘要】目的：探讨低分子肝素对脓毒症患者凝血功能的影响。方法：选取201

Abstract】Objective: To investigate the effect of low molecular weight heparin on blood coagulation function in patients with sepsis. Methods: A total of 112 patients with sepsis admitted from December 2015 to December 2020 were selected and divided into a control group and an anticoagulation group with 40 cases each according to a random number table. The control group received conventional treatment, and the anticoagulation group was treated with low molecular weight heparin on the basis of the conventional treatment in the control group. Compare the changes of related indexes of coagulation function between the two groups of patients. Results: After 3 and 7 days of treatment, the platelets, prothrombin time, activated partial prothrombin time, fibrinogen, and D-dimer in the anticoagulation group were improved compared with before treatment, and the platelets and D-dimer of the anticoagulation group were improved. The aggregate level was higher than the control group, and the difference was statistically significant (P0.05). Conclusion: Low molecular weight heparin treatment can improve blood coagulation function in patients with sepsis.

Abstract: To explore the effect of low molecular heparin on blood clotting function in patients with sepsis. Methods: 112 patients with sepsis were selected from December 2015 to December 2020, and 40 cases were divided into control group and anticoagulant group according to random numeric table. The control group was treated regularly, and the anticoagulant group increased the treatment of low molecular heparin on the basis of the conventional treatment in the control group. The changes in blood clotting-related indicators were compared with between the two groups of patients. Results: After 3 days and 7 days of treatment, the anticoagulant plate, clotting enzyme original time, active partial clotting enzyme original time, fibrinogen, D-d polymer were all improved before treatment, and anticoagulant plate plateboard, D-d polymer water level was higher than that of the control group, the difference was statistically significant (P05). Conclusion: Low-molecular heparin therapy can improve blood clotting in patients with sepsis.

Objective: To investigate the effect of low molecular weight heparin on coagulation function in patients with sepsis. Methods: 112 patients with sepsis from December 2015 to December 2020 were randomly divided into control group and anticoagulation group, 40 cases in each group. The control group received conventional treatment, while the anticoagulation group received low molecular weight heparin on the basis of conventional treatment. The changes of coagulation function related indexes were compared between the two groups. Results: after 3 days and 7 days of treatment, the platelet, prothrombin time, activated partial prothrombin time, fibrinogen and D-Dimer of anticoagulant group were improved, and the levels of platelet and D-Dimer of anticoagulant group were higher than those of control group (P 0.05). Conclusion: LMWH can improve the coagulation function of patients with sepsis.